Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Proteinase Activated Receptor 2
88%
Sunitinib
88%
Calcium Calmodulin Dependent Protein Kinase II
81%
Rat
71%
Purinergic P2Y12 Receptor
61%
Cardiotoxicity
54%
Protein Tyrosine Kinase Inhibitor
52%
Purinergic P2Y1 Receptor
50%
Imatinib
39%
Calcium Ion
38%
Drug
35%
Adenosine Diphosphate
33%
Osteosarcoma
33%
Malignant Neoplasm
29%
Bone Cancer
24%
Short Hairpin RNA
22%
Thromboxane Receptor
22%
Thromboxane A2 Receptor
22%
Thrombocyte Dysfunction
22%
Connexin 43
22%
Tumor Necrosis Factor
22%
G Protein Coupled Receptor
22%
Tumor Necrosis Factor
22%
Malignant Neoplasm
22%
Mitogen Activated Protein Kinase
22%
Phosphotransferase
22%
Stromal Cell Derived Factor 1
22%
Luciferase
22%
Cytokine
22%
Calmodulin
22%
I Kappa B Kinase Alpha
22%
RNA-Sequencing
22%
Pharmacodynamics
22%
Purinergic P2Y Receptor
21%
Agonist
20%
Immunoprecipitation
19%
Peptide
15%
Volume of Distribution
14%
Bleeding Disorder
11%
Antiangiogenic
11%
Dimer
11%
Heart Failure with Preserved Ejection Fraction
11%
Cell Marker
11%
Proteinase Activated Receptor
11%
Tumor Microenvironment
11%
Neoplasm
11%
Chemokine Receptor CXCR4
11%
Antibodies
11%
Cardiovascular Inflammation
11%
Biochemistry, Genetics and Molecular Biology
Fibroblast
88%
Protein Kinase
81%
Calmodulin
81%
Sunitinib
66%
Interleukin-1
66%
Rat
53%
Tyrosine Kinase Inhibitor
47%
Cancer Cell
44%
Imatinib
39%
Phosphorylation
39%
Alpha Oxidation
28%
Thrombin
26%
Calcium
25%
Regulatory Mechanism
23%
Proteases
22%
Internalization
22%
P2Y12
22%
Sphingosine Kinase 1
22%
Doxorubicin
22%
Arrestin
22%
Thromboxane A2
22%
Oxidative Stress
22%
Lifespan
22%
Cell Membrane
22%
Differential Display
22%
Independent Pathway
22%
Connexin
22%
Fluorescence
22%
Von Willebrand Disease
22%
Cell Proliferation
22%
High-Mobility Group
22%
Cancer Cell
22%
Cytokine
22%
RNA Sequence
22%
Gene
22%
Cell Division
22%
Platelet
17%
Thromboxane Receptor
16%
Tissue Section
16%
Kinase
14%
Western Blot
14%
Cell Death
13%
Signal Transduction
11%
Protein
11%
G Protein Coupled Receptor
11%
U46619
11%
CXCL5
11%
Osteoclast
11%
Osteoclast Activity
11%
FOXM1
11%
Medicine and Dentistry
Purinergic P2Y12 Receptor
83%
Receptor
79%
G Protein Coupled Receptor
78%
Platelet
56%
Purinergic P2Y1 Receptor
50%
Regulatory Mechanism
44%
Inpatient
38%
Therapeutic Procedure
35%
Patient
34%
Hypertension
27%
Cardiotoxicity
27%
Receptor Gene
27%
Development
27%
Adenosine Diphosphate
26%
Student
26%
Thrombocyte Function
24%
Antagonist
22%
Assessment
22%
Mitochondrial ROS
22%
Sunitinib
22%
Anticarcinogen
22%
Tumor Necrosis Factor
22%
Proteinase Activated Receptor 4
22%
Connexin 43
22%
Fibroblast
22%
Adult
22%
Proteinase Activated Receptor 2
22%
Thrombin
22%
Calcium Ion
22%
Protein
22%
Isotopes of Calcium
22%
Angiotensin
22%
Breast Cancer
22%
Storytelling
22%
Patient Experience
22%
Skeletal Muscle
22%
Single Nucleotide Polymorphism
18%
Cell Surface
17%
Cardiovascular Physiology
15%
Purinergic P2Y Receptor
15%
Volume of Distribution
14%
Cardiovascular Inflammation
14%
Cardiovascular Disease
13%
Internalization
12%
Dimer
11%
Artery Thrombosis
11%
Ligation
11%
Assay
11%
Myocyte
11%
Rest
11%